| AbbVie Inc. | Common | $935K | 0.4% | 5,037 SH | New |
| Alkermes PLC | Common | $1.4M | 0.6%Prev: 2.5% | 49,000 SH | Decreased-71,000 SH |
| AllianceBernstein Holding L.P. | Common | $2.0M | 0.9%Prev: 1.1% | 48,000 SH | Increased |
| Alphabet Inc CL A | Common | $53K | 0.0%Prev: 0.1% | 300 SH | Decreased |
| Alphabet Inc-Cl C | Common | $19.9M | 9.0%Prev: 15.6% | 112,220 SH | Decreased+20,800 SH |
| Amazon.com Inc. | Common | $66K | 0.0%Prev: 0.0% | 300 SH | Increased |
| Apollo Global Management, Inc. | Common | $31.9M | 14.5%Prev: 14.9% | 225,000 SH | Increased |
| Apple Inc. | Common | $512K | 0.2%Prev: 0.4% | 2,494 SH | Decreased |
| Arc Resources Ltd. | Common | $23K | 0.0% | 1,110 SH | New |
| Arcellx Inc | Common | $1.7M | 0.8%Prev: 1.3% | 25,700 SH | Decreased+6,267 SH |
| Arcus Biosciences, Inc. | Common | $570K | 0.3%Prev: 1.0% | 70,000 SH | Decreased-11,241 SH |
| AtriCure, Inc. | Common | $1.5M | 0.7%Prev: 0.9% | 46,443 SH | Increased-4,957 SH |
| aTyr Pharma, Inc. | Common | $255K | 0.1% | 50,367 SH | New |
| Autolus Therapeutics PLC | Common | $616K | 0.3% | 270,000 SH | New |
| Avadel Pharmaceuticals plc | Common | $3.8M | 1.7% | 426,000 SH | New |
| Axsome Therapeutics, Inc. | Common | $626K | 0.3% | 6,000 SH | New |
| BioCryst Pharmaceuticals, Inc. | Common | $3.0M | 1.4% | 332,625 SH | New |
| Blackstone Group LP | Common | $31K | 0.0%Prev: 0.0% | 210 SH | Increased |
| Bridgebio Pharma, Inc. | Common | $3.5M | 1.6%Prev: 4.0% | 80,000 SH | Decreased-10,000 SH |
| Bristol-Myers Squibb Company | Common | $1.2M | 0.6%Prev: 0.5% | 27,000 SH | Increased+13,378 SH |
| Broadcom, Inc. | Common | $196K | 0.1%Prev: 0.1% | 710 SH | Decreased |
| Calumet, Inc. | Common | $51.6M | 23.4% | 3,275,231 SH | New |
| Canadian Natural Resources Limited | Common | $528K | 0.2%Prev: 0.5% | 16,800 SH | Decreased |
| Catalyst Pharmaceuticals, Inc. | Common | $3.8M | 1.7%Prev: 1.8% | 176,000 SH | Increased+56,000 SH |
| Coca-Cola Co. | Common | $142K | 0.1% | 2,000 SH | New |
| Collegium Pharmaceutical, Inc. | Common | $695K | 0.3% | 23,511 SH | New |
| Corteva, Inc. | Common | $824K | 0.4%Prev: 0.1% | 11,051 SH | Increased+9,845 SH |
| CSX Corporation | Common | $2.3M | 1.0% | 70,000 SH | New |
| Cybin Inc | Common | $561K | 0.3%Prev: 1.0% | 66,880 SH | Decreased-283,120 SH |
| Danaher Corporation | Common | $36K | 0.0%Prev: 0.0% | 180 SH | Increased |
| Day One Biopharmaceuticals, Inc. | Common | $219K | 0.1% | 33,714 SH | New |
| DocGo, Inc. | Common | $4.8M | 2.2%Prev: 1.0% | 3,070,850 SH | Increased+400,000 SH |
| Dow Inc. | Common | $32K | 0.0%Prev: 0.0% | 1,206 SH | Decreased |
| DuPont de Nemours, Inc. | Common | $646K | 0.3%Prev: 0.1% | 9,418 SH | Increased+5,651 SH |
| Eastern Bankshares Inc | Common | $76K | 0.0%Prev: 0.1% | 5,000 SH | Decreased |
| Eli Lilly & Co. | Common | $234K | 0.1% | 300 SH | New |
| Enstar Group Limited | Common | $2.5M | 1.1% | 7,500 SH | New |
| FS Bancorp, Inc. | Common | $57K | 0.0% | 1,460 SH | New |
| FS KKR Capital Corp. | Common | $60K | 0.0%Prev: 0.0% | 2,875 SH | Increased |
| GE HealthCare Technologies Inc | Common | $4K | 0.0%Prev: 0.0% | 50 SH | Increased |
| Inozyme Pharma, Inc. | Common | $2.7M | 1.2% | 666,204 SH | New |
| International Business Machines | Common | $631K | 0.3%Prev: 0.3% | 2,142 SH | Increased |
| International Game Technology PLC | Common | $40K | 0.0% | 2,500 SH | New |
| iShares Nasdaq Biotechnology ETF | Common | $253K | 0.1% | 2,000 SH | New |
| iShares Russell Mid-Cap Growth | Common | $96K | 0.0%Prev: 0.1% | 695 SH | Increased |
| Janus Henderson AAA CLO ETF | Common | $25.1M | 11.4%Prev: 2.8% | 495,254 SH | Increased+401,726 SH |
| Johnson & Johnson | Common | $1.1M | 0.5%Prev: 0.7% | 6,922 SH | Decreased+2,000 SH |
| JPMorgan Chase & Co. | Common | $6.1M | 2.8%Prev: 3.4% | 20,985 SH | Increased+1,508 SH |
| Kimberly-Clark Corporation | Common | $774K | 0.4%Prev: 0.1% | 6,000 SH | Increased+3,600 SH |
| Kyndryl Holdings Inc. | Common | $18K | 0.0%Prev: 0.0% | 428 SH | Increased |
| Legacy Housing Corporation | Common | $91K | 0.0%Prev: 0.0% | 4,000 SH | Increased |
| LENZ Therapeutics, Inc. | Common | $2.4M | 1.1%Prev: 0.2% | 82,000 SH | Increased+48,268 SH |
| Liquidia Corporation | Common | $1.1M | 0.5% | 90,000 SH | New |
| Madrigal Pharmaaceuticals, Inc. | Common | $605K | 0.3%Prev: 0.6% | 2,000 SH | Decreased |
| Mereo BioPharm Group PLC | Common | $865K | 0.4%Prev: 0.1% | 319,337 SH | Increased+19,000 SH |
| Microsoft Corporation | Common | $796K | 0.4%Prev: 0.4% | 1,600 SH | Increased |
| Mondelez International Inc. | Common | $607K | 0.3% | 9,000 SH | New |
| Myriad Genetics, Inc. | Common | $956K | 0.4% | 180,000 SH | New |
| Nvidia Corp | Common | $202K | 0.1%Prev: 0.1% | 1,280 SH | Decreased |
| Occidental Petroleum Corporation | Common | $20K | 0.0%Prev: 0.0% | 469 SH | Decreased |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4K | 0.0%Prev: 0.0% | 194 SH | |
| Orchestra Biomed Holdings, Inc. | Common | $268K | 0.1%Prev: 0.6% | 100,000 SH | Decreased-153,651 SH |
| Pfizer Inc. | Common | $1.8M | 0.8%Prev: 0.5% | 74,537 SH | Increased+42,200 SH |
| Protagonist Therapeutics, Inc | Common | $4.4M | 2.0%Prev: 4.0% | 80,000 SH | Decreased+17,000 SH |
| Quanta Services, Inc. | Common | $67K | 0.0%Prev: 0.1% | 176 SH | Decreased |
| Ryman Hospitality Properties, Inc. | Common | $1.2M | 0.5%Prev: 0.1% | 12,000 SH | Increased+9,600 SH |
| Salesforce, Inc. | Common | $21K | 0.0%Prev: 0.0% | 77 SH | Increased |
| Solid Bioscience Inc. | Common | $791K | 0.4%Prev: 0.2% | 162,440 SH | Increased+115,297 SH |
| SPDR S&P Biotech ETF | Common | $249K | 0.1%Prev: 1.1% | 3,000 SH | Decreased-12,000 SH |
| Starwood Property Trust, Inc. | Common | $8K | 0.0%Prev: 0.0% | 400 SH | Increased |
| Syndax Pharmaceutical, Inc. | Common | $3.3M | 1.5%Prev: 5.9% | 352,778 SH | Decreased-69,222 SH |
| Tectonic Therapeutic, Inc. | Common | $1.5M | 0.7% | 74,000 SH | New |
| The Panagram BBB-B CLO ETF | Common | $1.3M | 0.6%Prev: 0.7% | 47,807 SH | Increased |
| Thermo Fisher Scientific, Inc. | Common | $18K | 0.0%Prev: 0.0% | 45 SH | Decreased |
| TotalEnergies SE - ADR | Common | $74K | 0.0% | 1,200 SH | New |
| Travere Therapeutics, Inc. | Common | $3.8M | 1.7%Prev: 2.5% | 260,000 SH | Decreased+119,367 SH |
| Ultragenyx Pharmaceutical Inc. | Common | $1.9M | 0.9%Prev: 0.4% | 52,000 SH | Increased+18,931 SH |
| United Healthcare Corp. | Common | $18K | 0.0%Prev: 0.0% | 57 SH | Increased |
| United Rental, Inc. | Common | $59K | 0.0%Prev: 0.0% | 78 SH | Increased |
| Vera Therapeutics, Inc. | Common | $471K | 0.2%Prev: 0.6% | 20,000 SH | Decreased-6,000 SH |
| Verona Pharma PLC. | Common | $5.2M | 2.4% | 55,000 SH | New |
| Viridian Therapeutics, Inc. | Common | $1.3M | 0.6%Prev: 2.1% | 91,483 SH | Decreased-89,517 SH |
| Wabtec Corporation | Common | $1K | 0.0%Prev: 0.0% | 6 SH | Decreased |
| Wave Life Science Ltd. | Common | $260K | 0.1%Prev: 0.2% | 40,000 SH | Decreased |
| Xenon Pharmaceuticals Inc. | Common | $343K | 0.2% | 10,962 SH | New |
| Xeris Biopharma Holdings, Inc. | Common | $5.0M | 2.2%Prev: 3.7% | 1,060,000 SH | Decreased |